3PC-010 Chemical interactions between antibiotics and cations administered by injection

由 Acrout, S, Cheikh, A, Mefetah, H, Zahidi, A, Idrissi, MOuled Bouyahya, Draoui, M, Bouatia, M
發表在 Eur J Hosp Pharm (2018)

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

由 Moody, T W, Zia, F, Draoui, M, Brenneman, D E, Fridkin, M, Davidson, A, Gozes, I
出版 1993

3PC-009 Physicochemical stability of intravenous injection of a generic product of furosemide prepared in polypropylene syringes

由 Chentoufi, M Alami, Bennis, S, Benabbes, M, Cheikh, A, Meftah, H, Zahidi, A, Idrissi, Mould Bouyahya, Draoui, M, Bouatia, M
發表在 Eur J Hosp Pharm (2018)

3PC-031 The influence of dead volume on reconstitution of injectable drugs

由 Hamdaoui, O El, Haoudi, M El, Attjioui, H, Cheikh, A, Mefetah, H, Rahali, y, Nejjari, R, Draoui, M, Bouatia, M
發表在 Eur J Hosp Pharm (2018)

3PC-034 Screening for physicochemical incompatibilities of cytotoxic drugs after reconstitution: the case of methotrexate

由 Chentoufi, M Alami, Nshimirimana, A, Benabbes, M, Bennis, S, Bennani, I, Zahidi, A, Cheikh, A, Idrissi, MOuld Bouyahya, Draoui, M, Bouatia, M
發表在 Eur J Hosp Pharm (2018)

3PC-033 In vitro physicochemical interactions study between iron and anticancer drugs administrated in hospital

由 Chentoufi, M Alami, Nshimirimana, A, Benabbes, M, Bennis, S, Mojemmi, B, Zahidi, A, Cheikh, A, Idrissi, MOuld Bouyahya, Draoui, M, Bouatia, M
發表在 Eur J Hosp Pharm (2018)